No. | Time to Arterial Puncture (h) | Target Vessel Location | Baseline NIHSS | TICI | Puncture to Recanalization Time (min) | Intravenous rtPA (mg/kg)a | Hemorrhagic Event According to ECASS Classifications5 | mRS at 90 Days | |
---|---|---|---|---|---|---|---|---|---|
Pre | Post | ||||||||
1 | 8.5 | BA | 23 | 0 | 2b | 80 | – | None | 1 |
2 | 3 | Lt M1 | 24 | 0 | 2b | 30 | 0.6 | None | 2 |
3 | 3 | Rt M1 | 19 | 0 | 2b | 15 | 0.6 | None | 1 |
4 | 4 | BA | 24 | 0 | 2a | 80 | 0.6 | Asymptomatic HI-2 | 5 |
5 | 4.5 | Rt M1 | 16 | 0 | 2b | 40 | 0.6 | None | 3 |
6 | 5.5 | Rt ICA | 16 | 0 | 2a | 50 | 0.9 | Asymptomatic HI-1 | 2 |
7 | 6 | Rt. M1 | 14 | 0 | 2b | 30 | – | None | 0 |
8 | 2.5 | Rt. M1 | 15 | 0 | 3 | 40 | 0.6 | None | 5 |
9 | 2.5 | Lt ICA | 21 | 0 | 3 | 25 | 0.6 | None | 6 |
10 | 6 | Rt ICA | 16 | 0 | 2a | 60 | 0.9 | None | 3 |
11 | 5.5 | Rt ICA | 16 | 0 | 3 | 40 | – | None | 3 |
12 | 4 | BA | 29 | 0 | 2a | 60 | – | Asymptomatic HI-2 | 5 |
13 | 5.5 | Lt M1 | 23 | 0 | 2b | 50 | 0.9 | None | 6 |
14 | 4 | Lt M1 | 11 | 0 | 3 | 60 | 0.6 | None | 4 |
15 | 8 | BA | 25 | 0 | 2b | 50 | – | Symptomatic PH-2 | 6 |
16 | 7 | Lt M1 | 20 | 0 | 3 | 15 | 0.6 | Symptomatic PH-1 | 3 |
17 | 6 | Rt M1 | 10 | 0 | 3 | 20 | – | None | 0 |
18 | 6 | Lt M1 | 12 | 0 | 2b | 10 | 0.6 | None | 0 |
19 | 5.5 | Rt M1 | 11 | 0 | 2b | 30 | – | None | 0 |
20 | 7 | Lt M1 | 18 | 0 | 2b | 50 | – | Asymptomatic HI-2 | 3 |
21 | 9 | Lt M1 | 14 | 0 | 3 | 30 | 0.6 | Asymptomatic HI-1 | 2 |
22 | 3 | Lt M1 | 20 | 0 | 3 | 15 | 0.9 | None | 2 |
a – indicates dosage of rtPA.